Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Teleflex Incorporated
Teleflex Incorporated News
Teleflex Incorporated Quantitative Score
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Teleflex Incorporated Earnings & Revenue
Teleflex Incorporated Financials
Table Compare
Compare TFX metrics with: | |||
---|---|---|---|
Earnings & Growth | TFX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | TFX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | TFX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | TFX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Teleflex Incorporated Income
Teleflex Incorporated Balance Sheet
Teleflex Incorporated Cash Flow
Teleflex Incorporated Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Neutral |
Return on Assets | Buy |
Debt/Equity Ratio | Sell |
Price/Earnings Ratio | Sell |
Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Teleflex Incorporated Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 1.3600 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-09-16 | 0.34 | Quarterly |
TBA | 0.34 | Quarterly |
2024-03-15 | 0.34 | Quarterly |
2023-12-15 | 0.34 | Quarterly |
2023-09-15 | 0.34 | Quarterly |
Teleflex Incorporated Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Teleflex Incorporated Executives
Name | Role |
---|---|
Mr. Liam J. Kelly | Chairman, President & Chief Executive Officer |
Mr. Thomas E. Powell BS, MBA | Executive Vice President & Chief Financial Officer |
Mr. Jay White | Corporate Vice President & President of Global Commercial |
Mr. Daniel V. Logue | Corporate Vice President, General Counsel & Secretary |
Mr. Cameron P. Hicks | Corporate Vice President & Chief Human Resources Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Liam J. Kelly | Chairman, President & Chief Executive Officer | Male | 1967 | 2.63M |
Mr. Thomas E. Powell BS, MBA | Executive Vice President & Chief Financial Officer | Male | 1962 | 1.29M |
Mr. Jay White | Corporate Vice President & President of Global Commercial | Male | 1974 | 1.09M |
Mr. Daniel V. Logue | Corporate Vice President, General Counsel & Secretary | Male | 1974 | 720.27K |
Mr. Cameron P. Hicks | Corporate Vice President & Chief Human Resources Officer | Male | 1965 | 564.68K |
Teleflex Incorporated Insider Trades
Date | 24 Aug |
Name | Deren John |
Role | Corp. VP & CAO |
Transaction | Disposed |
Type | F-InKind |
Shares | 16 |
Date | 16 Aug |
Name | RANDLE STUART A |
Role | Director |
Transaction | Acquired |
Type | M-Exempt |
Shares | 2674 |
Date | 16 Aug |
Name | RANDLE STUART A |
Role | Director |
Transaction | Disposed |
Type | S-Sale |
Shares | 2674 |
Date | 16 Aug |
Name | RANDLE STUART A |
Role | Director |
Transaction | Disposed |
Type | M-Exempt |
Shares | 2674 |
Date | 27 Feb |
Name | Winters James |
Role | Corp VP, Mfg and Supply |
Transaction | Acquired |
Type | A-Award |
Shares | 1126 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
24 Aug | Deren John | Corp. VP & CAO | Disposed | F-InKind | 16 |
16 Aug | RANDLE STUART A | Director | Acquired | M-Exempt | 2674 |
16 Aug | RANDLE STUART A | Director | Disposed | S-Sale | 2674 |
16 Aug | RANDLE STUART A | Director | Disposed | M-Exempt | 2674 |
27 Feb | Winters James | Corp VP, Mfg and Supply | Acquired | A-Award | 1126 |